Skandinaviska Enskilda Banken (SEB)’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-108,100
| Closed | -$1.23M | – | 1089 |
|
|
2020
Q2 | $1.23M | Buy |
108,100
+5,000
| +5% | +$56.7K | 0.01% | 686 |
|
|
2020
Q1 | $1.48M | Buy |
103,100
+15,300
| +17% | +$219K | 0.01% | 557 |
|
|
2019
Q4 | $2.39M | Buy |
87,800
+7,300
| +9% | +$199K | 0.02% | 512 |
|
|
2019
Q3 | $2.31M | Sell |
80,500
-13,700
| -15% | -$392K | 0.02% | 497 |
|
|
2019
Q2 | $2.62M | Sell |
94,200
-4,500
| -5% | -$125K | 0.02% | 439 |
|
|
2019
Q1 | $3.28M | Buy |
98,700
+6,900
| +8% | +$229K | 0.03% | 358 |
|
|
2018
Q4 | $2.67M | Buy |
91,800
+8,600
| +10% | +$250K | 0.02% | 396 |
|
|
2018
Q3 | $3.83M | Buy |
83,200
+9,900
| +14% | +$455K | 0.03% | 348 |
|
|
2018
Q2 | $2.74M | Sell |
73,300
-20,200
| -22% | -$755K | 0.02% | 366 |
|
|
2018
Q1 | $2.76M | Sell |
93,500
-400
| -0.4% | -$11.8K | 0.03% | 314 |
|
|
2017
Q4 | $3.23M | Sell |
93,900
-46,800
| -33% | -$1.61M | 0.03% | 349 |
|
|
2017
Q3 | $5.09M | Buy |
140,700
+6,300
| +5% | +$228K | 0.05% | 286 |
|
|
2017
Q2 | $3.47M | Sell |
134,400
-51,400
| -28% | -$1.33M | 0.03% | 357 |
|
|
2017
Q1 | $3.57M | Sell |
185,800
-36,300
| -16% | -$697K | 0.04% | 342 |
|
|
2016
Q4 | $3.7M | Sell |
222,100
-20,900
| -9% | -$348K | 0.04% | 280 |
|
|
2016
Q3 | $5M | Buy |
243,000
+62,100
| +34% | +$1.28M | 0.05% | 260 |
|
|
2016
Q2 | $5.54M | Buy |
180,900
+17,800
| +11% | +$545K | 0.06% | 227 |
|
|
2016
Q1 | $6.11M | Sell |
163,100
-24,400
| -13% | -$913K | 0.07% | 211 |
|
|
2015
Q4 | $8.09M | Buy |
+187,500
| New | +$8.09M | 0.1% | 148 |
|